Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash & Equivalents: 2023-2024

Historic Cash & Equivalents for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $325.9 million.

  • Upstream Bio's Cash & Equivalents rose 119.02% to $72.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.2 million, marking a year-over-year increase of 119.02%. This contributed to the annual value of $325.9 million for FY2024, which is 1161.53% up from last year.
  • Upstream Bio's Cash & Equivalents amounted to $325.9 million in FY2024, which was up 1,161.53% from $25.8 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Cash & Equivalents registered a high of $325.9 million during FY2024, and its lowest value of $25.8 million during FY2023.
  • In the last 2 years, Upstream Bio's Cash & Equivalents had a median value of $175.9 million in 2023 and averaged $175.9 million.
  • Data for Upstream Bio's Cash & Equivalents shows a peak YoY soared of 1,161.53% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Cash & Equivalents (Yearly) stood at $25.8 million in 2023, then surged by 1,161.53% to $325.9 million in 2024.